Abstract
Summary
Atrophic Medical Beauty Injections are a kind of medical beauty products that reduce wrinkles or break down fat
The global market for Atrophic Medical Beauty Injections was estimated to be worth US$ 632 million in 2023 and is forecast to a readjusted size of US$ 929.6 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Atrophic Medical Beauty Injections, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Atrophic Medical Beauty Injections by region & country, by Type, and by Application.
The Atrophic Medical Beauty Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atrophic Medical Beauty Injections.
Market Segmentation
By Company
Galderma
AbbVie
Croma-Pharma GmbH
Lanzhou Institute of Biological Products
Ipsen
Hugel
Segment by Type:
Reduce Wrinkles
Dissolve Tissues
Others
Segment by Application
Medical Beauty Institution
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Atrophic Medical Beauty Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Atrophic Medical Beauty Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Atrophic Medical Beauty Injections in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Atrophic Medical Beauty Injections was estimated to be worth US$ 632 million in 2023 and is forecast to a readjusted size of US$ 929.6 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Atrophic Medical Beauty Injections, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Atrophic Medical Beauty Injections by region & country, by Type, and by Application.
The Atrophic Medical Beauty Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atrophic Medical Beauty Injections.
Market Segmentation
By Company
Galderma
AbbVie
Croma-Pharma GmbH
Lanzhou Institute of Biological Products
Ipsen
Hugel
Segment by Type:
Reduce Wrinkles
Dissolve Tissues
Others
Segment by Application
Medical Beauty Institution
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Atrophic Medical Beauty Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Atrophic Medical Beauty Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Atrophic Medical Beauty Injections in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Atrophic Medical Beauty Injections Product Introduction
1.2 Global Atrophic Medical Beauty Injections Market Size Forecast
1.2.1 Global Atrophic Medical Beauty Injections Sales Value (2019-2030)
1.2.2 Global Atrophic Medical Beauty Injections Sales Volume (2019-2030)
1.2.3 Global Atrophic Medical Beauty Injections Sales Price (2019-2030)
1.3 Atrophic Medical Beauty Injections Market Trends & Drivers
1.3.1 Atrophic Medical Beauty Injections Industry Trends
1.3.2 Atrophic Medical Beauty Injections Market Drivers & Opportunity
1.3.3 Atrophic Medical Beauty Injections Market Challenges
1.3.4 Atrophic Medical Beauty Injections Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Atrophic Medical Beauty Injections Players Revenue Ranking (2023)
2.2 Global Atrophic Medical Beauty Injections Revenue by Company (2019-2024)
2.3 Global Atrophic Medical Beauty Injections Players Sales Volume Ranking (2023)
2.4 Global Atrophic Medical Beauty Injections Sales Volume by Company Players (2019-2024)
2.5 Global Atrophic Medical Beauty Injections Average Price by Company (2019-2024)
2.6 Key Manufacturers Atrophic Medical Beauty Injections Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Atrophic Medical Beauty Injections Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Atrophic Medical Beauty Injections
2.9 Atrophic Medical Beauty Injections Market Competitive Analysis
2.9.1 Atrophic Medical Beauty Injections Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Atrophic Medical Beauty Injections Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atrophic Medical Beauty Injections as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Reduce Wrinkles
3.1.2 Dissolve Tissues
3.1.3 Others
3.2 Global Atrophic Medical Beauty Injections Sales Value by Type
3.2.1 Global Atrophic Medical Beauty Injections Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Atrophic Medical Beauty Injections Sales Value, by Type (2019-2030)
3.2.3 Global Atrophic Medical Beauty Injections Sales Value, by Type (%) (2019-2030)
3.3 Global Atrophic Medical Beauty Injections Sales Volume by Type
3.3.1 Global Atrophic Medical Beauty Injections Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Atrophic Medical Beauty Injections Sales Volume, by Type (2019-2030)
3.3.3 Global Atrophic Medical Beauty Injections Sales Volume, by Type (%) (2019-2030)
3.4 Global Atrophic Medical Beauty Injections Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical Beauty Institution
4.1.2 Hospital
4.1.3 Others
4.2 Global Atrophic Medical Beauty Injections Sales Value by Application
4.2.1 Global Atrophic Medical Beauty Injections Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Atrophic Medical Beauty Injections Sales Value, by Application (2019-2030)
4.2.3 Global Atrophic Medical Beauty Injections Sales Value, by Application (%) (2019-2030)
4.3 Global Atrophic Medical Beauty Injections Sales Volume by Application
4.3.1 Global Atrophic Medical Beauty Injections Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Atrophic Medical Beauty Injections Sales Volume, by Application (2019-2030)
4.3.3 Global Atrophic Medical Beauty Injections Sales Volume, by Application (%) (2019-2030)
4.4 Global Atrophic Medical Beauty Injections Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Atrophic Medical Beauty Injections Sales Value by Region
5.1.1 Global Atrophic Medical Beauty Injections Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Atrophic Medical Beauty Injections Sales Value by Region (2019-2024)
5.1.3 Global Atrophic Medical Beauty Injections Sales Value by Region (2025-2030)
5.1.4 Global Atrophic Medical Beauty Injections Sales Value by Region (%), (2019-2030)
5.2 Global Atrophic Medical Beauty Injections Sales Volume by Region
5.2.1 Global Atrophic Medical Beauty Injections Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Atrophic Medical Beauty Injections Sales Volume by Region (2019-2024)
5.2.3 Global Atrophic Medical Beauty Injections Sales Volume by Region (2025-2030)
5.2.4 Global Atrophic Medical Beauty Injections Sales Volume by Region (%), (2019-2030)
5.3 Global Atrophic Medical Beauty Injections Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Atrophic Medical Beauty Injections Sales Value, 2019-2030
5.4.2 North America Atrophic Medical Beauty Injections Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Atrophic Medical Beauty Injections Sales Value, 2019-2030
5.5.2 Europe Atrophic Medical Beauty Injections Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Atrophic Medical Beauty Injections Sales Value, 2019-2030
5.6.2 Asia Pacific Atrophic Medical Beauty Injections Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Atrophic Medical Beauty Injections Sales Value, 2019-2030
5.7.2 South America Atrophic Medical Beauty Injections Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Atrophic Medical Beauty Injections Sales Value, 2019-2030
5.8.2 Middle East & Africa Atrophic Medical Beauty Injections Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Atrophic Medical Beauty Injections Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Atrophic Medical Beauty Injections Sales Value
6.2.1 Key Countries/Regions Atrophic Medical Beauty Injections Sales Value, 2019-2030
6.2.2 Key Countries/Regions Atrophic Medical Beauty Injections Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Atrophic Medical Beauty Injections Sales Value, 2019-2030
6.3.2 United States Atrophic Medical Beauty Injections Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Atrophic Medical Beauty Injections Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Atrophic Medical Beauty Injections Sales Value, 2019-2030
6.4.2 Europe Atrophic Medical Beauty Injections Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Atrophic Medical Beauty Injections Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Atrophic Medical Beauty Injections Sales Value, 2019-2030
6.5.2 China Atrophic Medical Beauty Injections Sales Value by Type (%), 2023 VS 2030
6.5.3 China Atrophic Medical Beauty Injections Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Atrophic Medical Beauty Injections Sales Value, 2019-2030
6.6.2 Japan Atrophic Medical Beauty Injections Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Atrophic Medical Beauty Injections Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Atrophic Medical Beauty Injections Sales Value, 2019-2030
6.7.2 South Korea Atrophic Medical Beauty Injections Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Atrophic Medical Beauty Injections Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Atrophic Medical Beauty Injections Sales Value, 2019-2030
6.8.2 Southeast Asia Atrophic Medical Beauty Injections Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Atrophic Medical Beauty Injections Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Atrophic Medical Beauty Injections Sales Value, 2019-2030
6.9.2 India Atrophic Medical Beauty Injections Sales Value by Type (%), 2023 VS 2030
6.9.3 India Atrophic Medical Beauty Injections Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Galderma
7.1.1 Galderma Company Information
7.1.2 Galderma Introduction and Business Overview
7.1.3 Galderma Atrophic Medical Beauty Injections Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Galderma Atrophic Medical Beauty Injections Product Offerings
7.1.5 Galderma Recent Development
7.2 AbbVie
7.2.1 AbbVie Company Information
7.2.2 AbbVie Introduction and Business Overview
7.2.3 AbbVie Atrophic Medical Beauty Injections Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AbbVie Atrophic Medical Beauty Injections Product Offerings
7.2.5 AbbVie Recent Development
7.3 Croma-Pharma GmbH
7.3.1 Croma-Pharma GmbH Company Information
7.3.2 Croma-Pharma GmbH Introduction and Business Overview
7.3.3 Croma-Pharma GmbH Atrophic Medical Beauty Injections Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Croma-Pharma GmbH Atrophic Medical Beauty Injections Product Offerings
7.3.5 Croma-Pharma GmbH Recent Development
7.4 Lanzhou Institute of Biological Products
7.4.1 Lanzhou Institute of Biological Products Company Information
7.4.2 Lanzhou Institute of Biological Products Introduction and Business Overview
7.4.3 Lanzhou Institute of Biological Products Atrophic Medical Beauty Injections Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Lanzhou Institute of Biological Products Atrophic Medical Beauty Injections Product Offerings
7.4.5 Lanzhou Institute of Biological Products Recent Development
7.5 Ipsen
7.5.1 Ipsen Company Information
7.5.2 Ipsen Introduction and Business Overview
7.5.3 Ipsen Atrophic Medical Beauty Injections Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ipsen Atrophic Medical Beauty Injections Product Offerings
7.5.5 Ipsen Recent Development
7.6 Hugel
7.6.1 Hugel Company Information
7.6.2 Hugel Introduction and Business Overview
7.6.3 Hugel Atrophic Medical Beauty Injections Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Hugel Atrophic Medical Beauty Injections Product Offerings
7.6.5 Hugel Recent Development
8 Industry Chain Analysis
8.1 Atrophic Medical Beauty Injections Industrial Chain
8.2 Atrophic Medical Beauty Injections Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Atrophic Medical Beauty Injections Sales Model
8.5.2 Sales Channel
8.5.3 Atrophic Medical Beauty Injections Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer